Use of high-dose cytarabine to enhance cisplatin cytotoxicity—effects on the response and overall survival rates of advanced head and neck cancer patients-Reference-Cited by-同舟云学术

Use of high-dose cytarabine to enhance cisplatin cytotoxicity—effects on the response and overall survival rates of advanced head and neck cancer patients

Published:2002-07 Issue:11 Volume:38 Page:1478-1489
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Jelić S,Stamatović Lj,Vučićević S,Petrović Ž,Kreačić M,Babović N,Jovanović N,Mikić A,Gavrilović D

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Six-year follow-up of stages III and IV (M0) head and neck cancer patients with chemotherapy pre-radical treatment;Carugati;Proc. Annu. Meat. Am. Soc. Clin. Oncol.,1985

2. Cis-dichlorodiamminoplatinum (II)-based chemotherapy as initial treatment of advanced head and neck cancer;Wittes;Cancer Treat Rep.,1979

3. Chemotherapy of head and neck cancer;Hamasaki;Curr. Opin. Oncol.,1992

4. Combined modalities in the treatment of head and neck cancers;Aisner;Semin. Oncol.,1995

5. Cisplatin plus a 5 day continuous infusion of 5 fluorouracil in the treatment of locally advanced and metastatic head and neck cancer patients;Palmeri;J. Cancer Res. Clin. Oncol.,1989

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M2-like tumor-associated macrophage-associated signatures from bulk and single-cell RNA-seq data may predict head and neck squamous cell carcinoma prognosis and immunotherapy response;2023-07-20

2. Head and neck cancer: a step forward;memo - Magazine of European Medical Oncology;2010-06

3. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review;Current Opinion in Oncology;2007-05

4. Guadagno di sopravvivenza dei nuovi farmaci;PharmacoEconomics Italian Research Articles;2004-07